• Overview
  • Eligibility
  • More info
  • Locations

Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain (NCT02897492)

Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain.
  • Other: Blood testing in a newly described method
    To exploit detection strategy termed "Magnetic Modulation Biosensing", or MMB) to develop a novel, low-cost platform that can detect biomarkers, such as proteins and specific DNA sequences, rapidly and directly from real samples at very low concentrations.
    Ages eligible for Study
    18 Years to 120 Years
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Inclusion Criteria:
    • Patients 18 years old or older
    • Admitted to Rambam health campus for the investigation of chest pain
    Exclusion Criteria:
    • No exclusion criteria will be applied
    Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain.

    A new diagnostic method will be applicated in the recent studies.
    Status:
    not yet recruiting
    Type:
    Observational
    Phase:
    -
    Start:
    31 August, 2016
    Updated:
    11 September, 2016
    Participants:
    500
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!